Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 46 entries
Sorted by: Best Match Show Resources per page
The relationship between the presence of autoantibodies, indicators of local and systemic inflammation, the serum concentration of B-cell activating factor (BAFF) and the intensity of salivary gland infiltration in patients with primary Sjögren's syndrome - a preliminary study.

Reumatologia

Maślińska M, Kontny E, Kwiatkowska B.
PMID: 27407265
Reumatologia. 2015;53(6):321-7. doi: 10.5114/reum.2015.57638. Epub 2016 Feb 11.

OBJECTIVES: The aim of this study was to find markers related to activation of B cells, which show a correlation with the systemic inflammation markers - erythrocyte sedimentation rate and C-reactive protein and with the intensity of in situ...

Cite
Maślińska M, Kontny E, Kwiatkowska B. The relationship between the presence of autoantibodies, indicators of local and systemic inflammation, the serum concentration of B-cell activating factor (BAFF) and the intensity of salivary gland infiltration in patients with primary Sjögren's syndrome - a preliminary study. Reumatologia. 2016;53(6):321-7doi: 10.5114/reum.2015.57638.
Maślińska, M., Kontny, E., & Kwiatkowska, B. (2015). The relationship between the presence of autoantibodies, indicators of local and systemic inflammation, the serum concentration of B-cell activating factor (BAFF) and the intensity of salivary gland infiltration in patients with primary Sjögren's syndrome - a preliminary study. Reumatologia, 53(6), 321-7. https://doi.org/10.5114/reum.2015.57638
Maślińska, Maria, et al. "The relationship between the presence of autoantibodies, indicators of local and systemic inflammation, the serum concentration of B-cell activating factor (BAFF) and the intensity of salivary gland infiltration in patients with primary Sjögren's syndrome - a preliminary study." Reumatologia vol. 53,6 (2015): 321-7. doi: https://doi.org/10.5114/reum.2015.57638
Maślińska M, Kontny E, Kwiatkowska B. The relationship between the presence of autoantibodies, indicators of local and systemic inflammation, the serum concentration of B-cell activating factor (BAFF) and the intensity of salivary gland infiltration in patients with primary Sjögren's syndrome - a preliminary study. Reumatologia. 2015;53(6):321-7. doi: 10.5114/reum.2015.57638. Epub 2016 Feb 11. PMID: 27407265; PMCID: PMC4847284.
Copy Download .nbib Format: NLM
Catastrophic antiphospholipid syndrome: proposed guidelines for diagnosis and treatment.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Asherson RA, Espinosa G, Cervera R, Font J, Reverter JC.
PMID: 17041346
J Clin Rheumatol. 2002 Jun;8(3):157-65.

The term "catastrophic" antiphospholipid syndrome (APS) was introduced to define an accelerated form of APS resulting in multi-organ failure. Although patients with the catastrophic form represent less than 1% of all patients with APS, they are usually in a...

Cite
Asherson RA, Espinosa G, Cervera R, et al. Catastrophic antiphospholipid syndrome: proposed guidelines for diagnosis and treatment. J Clin Rheumatol. 2002;8(3):157-65
Asherson, R. A., Espinosa, G., Cervera, R., Font, J., & Reverter, J. C. (2002). Catastrophic antiphospholipid syndrome: proposed guidelines for diagnosis and treatment. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 8(3), 157-65.
Asherson, Ronald A, et al. "Catastrophic antiphospholipid syndrome: proposed guidelines for diagnosis and treatment." Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases vol. 8,3 (2002): 157-65.
Asherson RA, Espinosa G, Cervera R, Font J, Reverter JC. Catastrophic antiphospholipid syndrome: proposed guidelines for diagnosis and treatment. J Clin Rheumatol. 2002 Jun;8(3):157-65. PMID: 17041346.
Copy Download .nbib Format: NLM
Diagnosis and Treatment of Chronic Immune-mediated Neuropathies.

Journal of clinical neuromuscular disease

Latov N, Gorson KC, Brannagan TH, Freeman RL, Apostolski S, Berger AR, Bradley WG, Briani C, Bril V, Busis NA, Cros DP, Dalakas MC, Donofrio PD, Dyck PJ, England JD, Fisher MA, Herrmann DN, Menkes DL, Sahenk Z, Sander HW, Triggs WJ, Vallat JM.
PMID: 19078800
J Clin Neuromuscul Dis. 2006 Mar;7(3):141-57. doi: 10.1097/01.cnd.0000205575.26451.e4.

The chronic autoimmune neuropathies are a diverse group of disorders, whose diagnosis and classification is based on the clinical presentations and results of ancillary tests. In chronic inflammatory demyelinating polyneuropathy, controlled therapeutic trials demonstrated efficacy for intravenous gamma-globulins, corticosteroids,...

Cite
Latov N, Gorson KC, Brannagan TH, et al. Diagnosis and Treatment of Chronic Immune-mediated Neuropathies. J Clin Neuromuscul Dis. 2006;7(3):141-57doi: 10.1097/01.cnd.0000205575.26451.e4.
Latov, N., Gorson, K. C., Brannagan, T. H., Freeman, R. L., Apostolski, S., Berger, A. R., Bradley, W. G., Briani, C., Bril, V., Busis, N. A., Cros, D. P., Dalakas, M. C., Donofrio, P. D., Dyck, P. J., England, J. D., Fisher, M. A., Herrmann, D. N., Menkes, D. L., Sahenk, Z., Sander, H. W., Triggs, W. J., & Vallat, J. M. (2006). Diagnosis and Treatment of Chronic Immune-mediated Neuropathies. Journal of clinical neuromuscular disease, 7(3), 141-57. https://doi.org/10.1097/01.cnd.0000205575.26451.e4
Latov, Norman, et al. "Diagnosis and Treatment of Chronic Immune-mediated Neuropathies." Journal of clinical neuromuscular disease vol. 7,3 (2006): 141-57. doi: https://doi.org/10.1097/01.cnd.0000205575.26451.e4
Latov N, Gorson KC, Brannagan TH, Freeman RL, Apostolski S, Berger AR, Bradley WG, Briani C, Bril V, Busis NA, Cros DP, Dalakas MC, Donofrio PD, Dyck PJ, England JD, Fisher MA, Herrmann DN, Menkes DL, Sahenk Z, Sander HW, Triggs WJ, Vallat JM. Diagnosis and Treatment of Chronic Immune-mediated Neuropathies. J Clin Neuromuscul Dis. 2006 Mar;7(3):141-57. doi: 10.1097/01.cnd.0000205575.26451.e4. PMID: 19078800.
Copy Download .nbib Format: NLM
The influence of sialic acid residues on the ability of glycoproteins toi nteract electrostatically with chondromucoprotein.

The Biochemical journal

Anderson AJ.
PMID: 16749134
Biochem J. 1965 Nov;97(2):333-9. doi: 10.1042/bj0970333.

1. Although glycoproteins with less than 1% of sialic acid (fibrinogen, lipoproteins, gamma-globulins) interact electrostatically with chondromucoprotein to form insoluble complexes, interaction with glycoproteins containing larger amounts of sialic acid (orosomucoid, urine glycoprotein, seromucoid, fraction VI) was electrostatically impossible....

Cite
Anderson AJ. The influence of sialic acid residues on the ability of glycoproteins toi nteract electrostatically with chondromucoprotein. Biochem J. 1965;97(2):333-9doi: 10.1042/bj0970333.
Anderson, A. J. (1965). The influence of sialic acid residues on the ability of glycoproteins toi nteract electrostatically with chondromucoprotein. The Biochemical journal, 97(2), 333-9. https://doi.org/10.1042/bj0970333
Anderson, A J. "The influence of sialic acid residues on the ability of glycoproteins toi nteract electrostatically with chondromucoprotein." The Biochemical journal vol. 97,2 (1965): 333-9. doi: https://doi.org/10.1042/bj0970333
Anderson AJ. The influence of sialic acid residues on the ability of glycoproteins toi nteract electrostatically with chondromucoprotein. Biochem J. 1965 Nov;97(2):333-9. doi: 10.1042/bj0970333. PMID: 16749134; PMCID: PMC1264644.
Copy Download .nbib Format: NLM
The disulphide bonds of human and rabbit gamma-globulins.

The Biochemical journal

Cecil R, Stevenson GT.
PMID: 16749166
Biochem J. 1965 Nov;97(2):569-72. doi: 10.1042/bj0970569.

1. The reaction of the disulphide bonds of the predominant species of human and rabbit gamma-globulins (the 7s gamma-globulins) with sulphite was studied in the presence and absence of denaturing agents and heavy-metal reagents. 2. The total number of...

Cite
Cecil R, Stevenson GT. The disulphide bonds of human and rabbit gamma-globulins. Biochem J. 1965;97(2):569-72doi: 10.1042/bj0970569.
Cecil, R., & Stevenson, G. T. (1965). The disulphide bonds of human and rabbit gamma-globulins. The Biochemical journal, 97(2), 569-72. https://doi.org/10.1042/bj0970569
Cecil, R, and Stevenson, G T. "The disulphide bonds of human and rabbit gamma-globulins." The Biochemical journal vol. 97,2 (1965): 569-72. doi: https://doi.org/10.1042/bj0970569
Cecil R, Stevenson GT. The disulphide bonds of human and rabbit gamma-globulins. Biochem J. 1965 Nov;97(2):569-72. doi: 10.1042/bj0970569. PMID: 16749166; PMCID: PMC1264677.
Copy Download .nbib Format: NLM
ANTIGENIC RELATIONSHIPS BETWEEN IMMUNE GLOBULINS AND CERTAIN RELATED PARAPROTEINS IN MAN.

The Journal of experimental medicine

Franklin EC, Stanworth DR.
PMID: 19867200
J Exp Med. 1961 Sep 30;114(4):521-33. doi: 10.1084/jem.114.4.521.

The antigenic properties of normal 19S gamma-globulin, pathologic macroglobulins, beta(2A)-myeloma proteins, and Bence Jones proteins have been compared with 7S gamma-globulin and the small 3.5S units derived from it by gel diffusion precipitin techniques. These studies demonstrate that the...

Cite
Franklin EC, Stanworth DR. ANTIGENIC RELATIONSHIPS BETWEEN IMMUNE GLOBULINS AND CERTAIN RELATED PARAPROTEINS IN MAN. J Exp Med. 1961;114(4):521-33doi: 10.1084/jem.114.4.521.
Franklin, E. C., & Stanworth, D. R. (1961). ANTIGENIC RELATIONSHIPS BETWEEN IMMUNE GLOBULINS AND CERTAIN RELATED PARAPROTEINS IN MAN. The Journal of experimental medicine, 114(4), 521-33. https://doi.org/10.1084/jem.114.4.521
Franklin, E C, and Stanworth, D R. "ANTIGENIC RELATIONSHIPS BETWEEN IMMUNE GLOBULINS AND CERTAIN RELATED PARAPROTEINS IN MAN." The Journal of experimental medicine vol. 114,4 (1961): 521-33. doi: https://doi.org/10.1084/jem.114.4.521
Franklin EC, Stanworth DR. ANTIGENIC RELATIONSHIPS BETWEEN IMMUNE GLOBULINS AND CERTAIN RELATED PARAPROTEINS IN MAN. J Exp Med. 1961 Sep 30;114(4):521-33. doi: 10.1084/jem.114.4.521. PMID: 19867200; PMCID: PMC2180369.
Copy Download .nbib Format: NLM
Alterations of insulin-like growth factor I (IGF-I) and estradiol serum levels in chronic hepatitis C.

Contemporary oncology (Poznan, Poland)

Adamek A, Kasprzak A, Seraszek A, Mikoś H, Bura A, Mozer-Lisewska I.
PMID: 23788886
Contemp Oncol (Pozn). 2012;16(3):234-9. doi: 10.5114/wo.2012.29291. Epub 2012 Jul 06.

AIM OF THE STUDY: Deregulation of insulin-like growth factor I (IGF-I) production and decreased hepatic estrogen levels were associated with development of hepatocellular carcinoma (HCC) in hepatitis C virus (HCV) infected cirrhotic patients. The aim of our study was...

Cite
Adamek A, Kasprzak A, Seraszek A, et al. Alterations of insulin-like growth factor I (IGF-I) and estradiol serum levels in chronic hepatitis C. Contemp Oncol (Pozn). 2012;16(3):234-9doi: 10.5114/wo.2012.29291.
Adamek, A., Kasprzak, A., Seraszek, A., Mikoś, H., Bura, A., & Mozer-Lisewska, I. (2012). Alterations of insulin-like growth factor I (IGF-I) and estradiol serum levels in chronic hepatitis C. Contemporary oncology (Poznan, Poland), 16(3), 234-9. https://doi.org/10.5114/wo.2012.29291
Adamek, Agnieszka, et al. "Alterations of insulin-like growth factor I (IGF-I) and estradiol serum levels in chronic hepatitis C." Contemporary oncology (Poznan, Poland) vol. 16,3 (2012): 234-9. doi: https://doi.org/10.5114/wo.2012.29291
Adamek A, Kasprzak A, Seraszek A, Mikoś H, Bura A, Mozer-Lisewska I. Alterations of insulin-like growth factor I (IGF-I) and estradiol serum levels in chronic hepatitis C. Contemp Oncol (Pozn). 2012;16(3):234-9. doi: 10.5114/wo.2012.29291. Epub 2012 Jul 06. PMID: 23788886; PMCID: PMC3687405.
Copy Download .nbib Format: NLM
Risk of infection according to the gamma globulin level in the 100 days following allogeneic stem cell transplantations.

European journal of haematology

Lacombe V, Nunes Gomes C, Robin JB, Thépot S, François S, Cottin L, Ugo V, Dieu X, Abgueguen P, Daniel V, Giltat A, Hunault M, Riou J, Orvain C, Schmidt A.
PMID: 34245060
Eur J Haematol. 2021 Oct;107(4):489-496. doi: 10.1111/ejh.13686. Epub 2021 Jul 18.

BACKGROUND: Immunoglobulin replacement therapy is recommended in case of severe hypogammaglobulinemia after allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, the supposed increased risk of infection in case of hypogammaglobulinemia has not been confirmed in allo-HSCT. In this study, we...

Cite
Lacombe V, Nunes Gomes C, Robin JB, et al. Risk of infection according to the gamma globulin level in the 100 days following allogeneic stem cell transplantations. Eur J Haematol. 2021;107(4):489-496doi: 10.1111/ejh.13686.
Lacombe, V., Nunes Gomes, C., Robin, J. B., Thépot, S., François, S., Cottin, L., Ugo, V., Dieu, X., Abgueguen, P., Daniel, V., Giltat, A., Hunault, M., Riou, J., Orvain, C., & Schmidt, A. (2021). Risk of infection according to the gamma globulin level in the 100 days following allogeneic stem cell transplantations. European journal of haematology, 107(4), 489-496. https://doi.org/10.1111/ejh.13686
Lacombe, Valentin, et al. "Risk of infection according to the gamma globulin level in the 100 days following allogeneic stem cell transplantations." European journal of haematology vol. 107,4 (2021): 489-496. doi: https://doi.org/10.1111/ejh.13686
Lacombe V, Nunes Gomes C, Robin JB, Thépot S, François S, Cottin L, Ugo V, Dieu X, Abgueguen P, Daniel V, Giltat A, Hunault M, Riou J, Orvain C, Schmidt A. Risk of infection according to the gamma globulin level in the 100 days following allogeneic stem cell transplantations. Eur J Haematol. 2021 Oct;107(4):489-496. doi: 10.1111/ejh.13686. Epub 2021 Jul 18. PMID: 34245060.
Copy Download .nbib Format: NLM
Measles: Progress and Failure.

The Ulster medical journal

Hedley-Whyte J, Milamed DR.
PMID: 34276090
Ulster Med J. 2021 May;90(2):107-111. Epub 2021 Jul 08.

No abstract available.

Cite
Hedley-Whyte J, Milamed DR. Measles: Progress and Failure. Ulster Med J. 2021;90(2):107-111
Hedley-Whyte, J., & Milamed, D. R. (2021). Measles: Progress and Failure. The Ulster medical journal, 90(2), 107-111.
Hedley-Whyte, John, and Milamed, Debra R. "Measles: Progress and Failure." The Ulster medical journal vol. 90,2 (2021): 107-111.
Hedley-Whyte J, Milamed DR. Measles: Progress and Failure. Ulster Med J. 2021 May;90(2):107-111. Epub 2021 Jul 08. PMID: 34276090; PMCID: PMC8278946.
Copy Download .nbib Format: NLM
Humoral response to mRNA anti-COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia.

Blood advances

Bagacean C, Letestu R, Al-Nawakil C, Brichler S, Lévy V, Sritharan N, Delmer AJ, Dartigeas C, Leblond V, Roos-Weil D, Tomowiak C, Merabet F, Béné MC, Clavert A, Chaoui D, Genet P, Guieze R, Laribi K, Drénou B, Willems L, Puppinck C, Legendre H, Troussard X, Malartre S, Cymbalista F, Michallet AS.
PMID: 34844264
Blood Adv. 2021 Nov 29; doi: 10.1182/bloodadvances.2021006215. Epub 2021 Nov 29.

Immunocompromised individuals such as chronic lymphocytic leukemia (CLL) patients are at risk of impaired immune responses to vaccination. The objective of our study was to evaluate SARS-CoV-2-specific antibody responses in CLL patients, after the first, second and third doses...

Cite
Bagacean C, Letestu R, Al-Nawakil C, et al. Humoral response to mRNA anti-COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia. Blood Adv. 2021;doi: 10.1182/bloodadvances.2021006215.
Bagacean, C., Letestu, R., Al-Nawakil, C., Brichler, S., Lévy, V., Sritharan, N., Delmer, A. J., Dartigeas, C., Leblond, V., Roos-Weil, D., Tomowiak, C., Merabet, F., Béné, M. C., Clavert, A., Chaoui, D., Genet, P., Guieze, R., Laribi, K., Drénou, B., Willems, L., Puppinck, C., Legendre, H., Troussard, X., Malartre, S., Cymbalista, F., & Michallet, A. S. (2021). Humoral response to mRNA anti-COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia. Blood advances, . https://doi.org/10.1182/bloodadvances.2021006215
Bagacean, Cristina, et al. "Humoral response to mRNA anti-COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia." Blood advances vol. (2021). doi: https://doi.org/10.1182/bloodadvances.2021006215
Bagacean C, Letestu R, Al-Nawakil C, Brichler S, Lévy V, Sritharan N, Delmer AJ, Dartigeas C, Leblond V, Roos-Weil D, Tomowiak C, Merabet F, Béné MC, Clavert A, Chaoui D, Genet P, Guieze R, Laribi K, Drénou B, Willems L, Puppinck C, Legendre H, Troussard X, Malartre S, Cymbalista F, Michallet AS. Humoral response to mRNA anti-COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia. Blood Adv. 2021 Nov 29; doi: 10.1182/bloodadvances.2021006215. Epub 2021 Nov 29. PMID: 34844264; PMCID: PMC8632355.
Copy Download .nbib Format: NLM
Immune Thrombocytopenia Revealing Enriched IgG-4 Peri-Renal Rosai-Dorfman Disease Successfully Treated with Rituximab: A Case Report and Literature Review.

Frontiers in medicine

Razanamahery J, Humbert S, Emile JF, Cohen-Aubart F, Fontan J, Maksud P, Audia S, Haroche J.
PMID: 34222286
Front Med (Lausanne). 2021 Jun 16;8:678456. doi: 10.3389/fmed.2021.678456. eCollection 2021.

Immune thrombocytopenia (ITP) is a rare autoimmune-mediated condition characterized by isolated thrombocytopenia (

Cite
Razanamahery J, Humbert S, Emile JF, et al. Immune Thrombocytopenia Revealing Enriched IgG-4 Peri-Renal Rosai-Dorfman Disease Successfully Treated with Rituximab: A Case Report and Literature Review. Front Med (Lausanne). 2021;8:678456doi: 10.3389/fmed.2021.678456.
Razanamahery, J., Humbert, S., Emile, J. F., Cohen-Aubart, F., Fontan, J., Maksud, P., Audia, S., & Haroche, J. (2021). Immune Thrombocytopenia Revealing Enriched IgG-4 Peri-Renal Rosai-Dorfman Disease Successfully Treated with Rituximab: A Case Report and Literature Review. Frontiers in medicine, 8678456. https://doi.org/10.3389/fmed.2021.678456
Razanamahery, Jerome, et al. "Immune Thrombocytopenia Revealing Enriched IgG-4 Peri-Renal Rosai-Dorfman Disease Successfully Treated with Rituximab: A Case Report and Literature Review." Frontiers in medicine vol. 8 (2021): 678456. doi: https://doi.org/10.3389/fmed.2021.678456
Razanamahery J, Humbert S, Emile JF, Cohen-Aubart F, Fontan J, Maksud P, Audia S, Haroche J. Immune Thrombocytopenia Revealing Enriched IgG-4 Peri-Renal Rosai-Dorfman Disease Successfully Treated with Rituximab: A Case Report and Literature Review. Front Med (Lausanne). 2021 Jun 16;8:678456. doi: 10.3389/fmed.2021.678456. eCollection 2021. PMID: 34222286; PMCID: PMC8244783.
Copy Download .nbib Format: NLM
Novel hydrophobic ligand-containing hydrogel membrane matrix: preparation and application to gamma-globulins adsorption.

Colloids and surfaces. B, Biointerfaces

Yakup Arica M, Akin-Öktem G, Denizli A.
PMID: 11397630
Colloids Surf B Biointerfaces. 2001 Aug;21(4):273-283. doi: 10.1016/s0927-7765(00)00209-5.

In this study, phenylalanine as a hydrophobic ligand was covalently attached to the co-monomer methacrylochloride. Then, poly(2-hydroxyethylmethacrylate-co-methacrylamidophenyalanine) [poly(HEMA-MAPA)] membranes were prepared by UV-initiated photopolymerization of HEMA and methacrylamidophenyalanine. The gamma-globulins adsorption onto these affinity membranes from aqueous solutions containing...

Cite
Yakup Arica M, Akin-Öktem G, Denizli A. Novel hydrophobic ligand-containing hydrogel membrane matrix: preparation and application to gamma-globulins adsorption. Colloids Surf B Biointerfaces. 2001;21(4):273-283doi: 10.1016/s0927-7765(00)00209-5.
Yakup Arica, M., Akin-Öktem, G., & Denizli, A. (2001). Novel hydrophobic ligand-containing hydrogel membrane matrix: preparation and application to gamma-globulins adsorption. Colloids and surfaces. B, Biointerfaces, 21(4), 273-283. https://doi.org/10.1016/s0927-7765(00)00209-5
Yakup Arica, M, et al. "Novel hydrophobic ligand-containing hydrogel membrane matrix: preparation and application to gamma-globulins adsorption." Colloids and surfaces. B, Biointerfaces vol. 21,4 (2001): 273-283. doi: https://doi.org/10.1016/s0927-7765(00)00209-5
Yakup Arica M, Akin-Öktem G, Denizli A. Novel hydrophobic ligand-containing hydrogel membrane matrix: preparation and application to gamma-globulins adsorption. Colloids Surf B Biointerfaces. 2001 Aug;21(4):273-283. doi: 10.1016/s0927-7765(00)00209-5. PMID: 11397630.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 46 entries